Corbus Pharmaceuticals Holdings, Inc.

NasdaqCM:CRBP Stock Report

Market Cap: US$158.3m

Corbus Pharmaceuticals Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRBP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Sep 24BuyUS$7,003,761Cormorant Asset Management, LPCompany350,000US$22.23
08 Mar 24BuyUS$23,327,560Cormorant Asset Management, LPCompany550,000US$45.96
02 Feb 24BuyUS$14,250,000Cormorant Asset Management, LPCompany750,000US$19.00
26 Jan 24BuyUS$9,111,941Cormorant Asset Management, LPCompany282,632US$38.49

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRBP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,8730.0221%
Individual Insiders16,3490.126%
VC/PE Firms912,5527.02%
Hedge Funds3,490,00026.8%
Institutions8,583,31166%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 175.3%.

Top Shareholders

Top 25 shareholders own 92.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
Cormorant Asset Management, LP
2,375,000US$30.9m17.3%1.75%
9.15%
Octagon Capital Advisors LP
1,115,000US$14.5m128%2.45%
7.49%
OrbiMed Advisors LLC
912,552US$11.9m0%0.18%
6.59%
BlackRock, Inc.
802,721US$10.4m5.43%no data
5.3%
The Vanguard Group, Inc.
645,650US$8.4m10.4%no data
4.93%
Tang Capital Management, LLC
600,000US$7.8m40.8%0.6%
4.89%
State Street Global Advisors, Inc.
595,576US$7.7m34.6%no data
4.34%
Adage Capital Management, L.P.
528,937US$6.9m32.2%0.01%
3.53%
RA Capital Management, L.P.
430,182US$5.6m0%0.07%
3.28%
Paradigm Biocapital Advisors LP
399,658US$5.2m0%0.2%
2.67%
T. Rowe Price Group, Inc.
325,668US$4.2m7.77%no data
2.63%
HBM Partners Ltd.
320,000US$4.2m0%0.44%
2.34%
Ikarian Capital, LLC
284,715US$3.7m-8.02%1.14%
2.05%
Geode Capital Management, LLC
249,759US$3.2m8.09%no data
1.82%
Assenagon Asset Management S.A.
221,184US$2.9m-7.36%0.01%
1.6%
Altium Capital Management LP
195,000US$2.5m0%0.84%
1.42%
Mirae Asset Global Investments Co., Ltd.
172,630US$2.2m473%no data
1.37%
Vivo Capital, LLC
166,794US$2.2m0%0.19%
1.31%
Ghost Tree Capital, LLC
160,000US$2.1m-8.57%0.85%
1.27%
Morgan Stanley, Investment Banking and Brokerage Investments
154,615US$2.0m-40%no data
1.18%
Schonfeld Strategic Advisors LLC
143,356US$1.9m2.18%0.02%
1.07%
Prosight Management, LP
130,000US$1.7m0%0.48%
1.06%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
128,990US$1.7m362%no data
1.05%
Driehaus Capital Management LLC
127,787US$1.7m103%0.01%
0.84%
Millennium Management LLC
102,751US$1.3m-57.5%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:09
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Corbus Pharmaceuticals Holdings, Inc. is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LeBoyerAegis Capital Corporation
Kalpit PatelB. Riley Securities, Inc.
George ZavoicoB. Riley Securities, Inc.